All Industries

Top Life Sciences Companies

1,069 Life Sciences companies, sorted by total funding raised.

CRISPRIPO

A Basel, Switzerland and Boston, MA-based biopharmaceutical company created to translate CRISPR-C...

Zug, Switzerland201–500Biotech, Healthcare
Venture RoundTotal funding$746.5MFeb 2024
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Chai Discovery

Chai Discovery builds frontier AI to predict and reprogram interactions between biochemical molec...

San Francisco, United States11–50Artificial Intelligence, Biotech
Series CTotal funding$630.0MJul 2026
Color

Population-scale health company delivering genetic testing, cancer screening, and virtual clinica...

Burlingame, United States501–1000Life Sciences, Biotech
Series ETotal funding$614.0MNov 2021
Aidoc

Aidoc provides clinical AI that analyzes medical data to help healthcare teams optimize treatment...

Tel Aviv, Israel201–500Life Sciences, Artificial Intelligence
Series ETotal funding$583.5MApr 2026
Rakuten Medical

Global biotechnology company developing and commercializing precision, cell-targeting therapies b...

San Diego, United StatesBiotech, Life Sciences
Series FTotal funding$575.0MJan 2026
Apprentice

Enterprise SaaS focused on human workforce empowerment in laboratory and manufacturing environments.

Jersey City, United States51–200Healthcare, Life Sciences
Series ETotal funding$562.0MJan 2025
Centessa PharmaceuticalsIPO

Centessa Pharmaceuticals is a next-gen biopharmaceutical company reshaping traditional drug devel...

United States51–200Healthcare, Life Sciences
Corporate RoundTotal funding$550.0MApr 2024
Sanfer

Sanfer is an independent pharmaceutical company based in Mexico, and operating in nine countries ...

Mexico City, Mexico10001+Life Sciences
Growth EquityTotal funding$500.0MAug 2019
nChroma Bio

Genetic medicines company developing targeted in vivo delivery and engineered epigenetic silencer...

Boston, United States51–200Biotech, Genomics
Venture RoundTotal funding$470.0MDec 2024
SynthegoAcquired

Synthego provides CRISPR solutions, reagents, and expertise that help researchers and therapeutic...

Redwood City, United States51–200Biotech, Genomics
Series ETotal funding$468.6MFeb 2022
ArvinasIPO

Arvinas develops targeted protein degradation medicines using its PROTAC platform for patients wi...

New Haven, United States201–500Biotech, Healthcare
Private EquityTotal funding$465.9MNov 2023
Sword

Sword Health provides AI Care programs that combine licensed clinicians and artificial intelligen...

New York, United States501–1000Life Sciences, Artificial Intelligence
Venture RoundTotal funding$464.6MJun 2025
BiofourmisAcquired

AI-driven platform delivering remote patient monitoring and in-home care for health systems, paye...

Boston, United States201–500Artificial Intelligence, Digital Health
Series DTotal funding$461.5MJul 2022
Crinetics Pharmaceuticals, Inc.Acquired

Crinetics develops and commercializes therapies for endocrine diseases and endocrine-related tumo...

San Diego, United States11–50Biotech, Healthcare
Venture RoundTotal funding$460.3MJan 2026
AlumisMerged

Alumis develops next-generation targeted oral therapies for people with immune-mediated diseases,...

South San Francisco, United States201–500Healthcare, Life Sciences
Series CTotal funding$459.0MMar 2024
Capital Rx

Full-service pharmacy benefits manager and administrator serving employers and health plans with ...

New York, United States501–1000Life Sciences, Healthcare
Series FTotal funding$452.3MSep 2025
GalectoIPO

Clinical-stage biotech developing small-molecule therapeutics targeting galectin and other mechan...

Copenhagen, Denmark11–50Biotech, Drug Discovery
Series CTotal funding$446.9MNov 2025
Charles River LaboratoriesIPO

Charles River Laboratories provides essential products and services that help pharmaceutical, bio...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$443.0MSep 1999
Areteia TherapeuticsClosed

Clinical-stage biotechnology company formerly based in Chapel Hill that is no longer operating an...

Chapel Hill, United States11–50Biotech, Life Sciences
Series ATotal funding$425.0MFeb 2024
Transcarent

Transcarent is the One Place for Health and Care that makes it easy for people to access high-qua...

San Francisco, United States501–1000Life Sciences, Artificial Intelligence
Venture RoundTotal funding$424.0MJan 2025
Verdiva Bio

Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative therap...

London, United Kingdom11–50Life Sciences, Biotech
Series ATotal funding$411.0MJan 2025
Meril Life

Meril Life designs and manufactures medical devices spanning surgical, diagnostic, orthopedic, va...

Vapi, India10001+Healthcare, Life Sciences
Private EquityTotal funding$410.0MJul 2025
Sonoma Biotherapeutics

Develops engineered regulatory T cell therapies to restore immune balance and treat autoimmune an...

Seattle, United States51–200Biotech, Life Sciences
Corporate RoundTotal funding$410.0MSep 2024